Jolanta Karpinski Selected Research

Jolanta Karpinski Research Topics

2	Infections 04/2023 - 03/2017
1	COVID-19 04/2023
1	Acute Kidney Injury (Acute Renal Failure) 04/2023
1	Hematologic Neoplasms (Hematological Malignancy) 01/2021
1	Neoplasms (Cancer) 01/2021
1	Listeriosis (Listeria Infection) 03/2017
1	Peritonitis 03/2017
1	Chronic Renal Insufficiency 03/2012
1	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 01/2008
1	Dyslipidemias (Dyslipidemia) 01/2007
1	Hypertension (High Blood Pressure) 01/2007
1	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 12/2005

2	CreatinineIBA 04/2023 - 03/2012
1	nirmatrelvir and ritonavir drug combinationIBA 04/2023
1	Tacrolimus (Prograf)FDA LinkGeneric 04/2023
1	Vancomycin FDA LinkGeneric 03/2017
1	Ampicillin (Omnipen)FDA LinkGeneric 03/2017
1	Gentamicins (Gentamicin)FDA LinkGeneric 03/2017
1	Rituximab (Mabthera)FDA Link 01/2008
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2007
1	Erythropoietin FDA Link 01/2007
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2007
1	Sirolimus (Rapamycin)FDA Link 12/2005